Mitochondrial
SS-31
The only peptide engineered to go exactly where mitochondrial damage happens. SS-31 binds to cardiolipin, a phospholipid found almost exclusively at the inner mitochondrial membrane, stabilising energy production and reducing oxidative damage at the source. Unlike broad-spectrum antioxidants, it does not act throughout the cell. It goes directly to the problem. This precision is what has driven SS-31 further in clinical development than almost any other mitochondria-targeted compound, including completed Phase 2 trials in cardiac research models. Studies have also linked SS-31 activity to reduced inflammatory markers including NFkB and TNF-alpha, connecting mitochondrial protection to broader cellular health pathways. The 30mg pen is designed for extended mitochondrial research protocols.
€59.90 · 10mg
Available options
Product information
The only peptide engineered to go exactly where mitochondrial damage happens. SS-31 binds to cardiolipin, a phospholipid found almost exclusively at the inner mitochondrial membrane, stabilising energy production and reducing oxidative damage at the source. Unlike broad-spectrum antioxidants, it does not act throughout the cell. It goes directly to the problem. This precision is what has driven SS-31 further in clinical development than almost any other mitochondria-targeted compound, including completed Phase 2 trials in cardiac research models. Studies have also linked SS-31 activity to reduced inflammatory markers including NFkB and TNF-alpha, connecting mitochondrial protection to broader cellular health pathways. The 30mg pen is designed for extended mitochondrial research protocols.